Imaging of myocarditis and inflammatory cardiomyopathies

Bière, Loïc; Meneveau, Nicolas; Ernande, Laura; Rouzet, François; Lairez, Olivier

doi:10.1016/j.acvd.2019.05.007

Cited by 24 publications

(22 citation statements)

References 80 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Transthoracic echocardiography (TTE) can help rule out other causes of heart failure such as myocardial infarction and valvular heart disease. 30 TTE findings can include global left ventricular hypokinesis, regional wall motion abnormalities, and dilated and/or hypertrophic ventricles. 31 In the case reports of suspected myocarditis in COVID-19 patients (Table 1), all TTEs revealed reduced left ventricular ejection fraction.…”

Section: What Pathophysiologic Mechanisms Arementioning

confidence: 99%

COVID-19 and Myocarditis: What Do We Know So Far?

2020

View full text Add to dashboard Cite

COVID-19 has been declared a global pandemic by the World Health Organization and is responsible for hundreds of thousands of deaths worldwide. COVID-19 is caused by SARS-CoV-2, and common clinical symptoms include fever, cough, sore throat, headache, and fatigue. Myocardial injury is relatively common in patients with COVID-19, accounting for 7%-23% of cases, and is associated with a higher rate of morbidity and mortality. There is a discrepancy in the literature about

show abstract

Section: What Pathophysiologic Mechanisms Arementioning

confidence: 99%

COVID-19 and Myocarditis: What Do We Know So Far?

2020

View full text Add to dashboard Cite

show abstract

“…Transthoracic echocardiogram (TTE) is the initial noninvasive imaging modality of choice since it can provide valuable data for diagnosing myocardial infarction, aortic root dissection, pericardial disease or valvular heart disease. Common TTE findings in myocarditis include new left ventricular (LV) wall motion abnormalities, diastolic dysfunction, myocardial edema, intraventricular thrombus, and pericardial effusion [19]. Interestingly, recently published study on echocardiographic findings in COVID-19 patients demonstrated that only a third of the hospitalized patients have normal biventricular function.…”

Section: Diagnosing Covid-19 Myocarditis: Use Of Cardiac Imagingmentioning

confidence: 99%

Contemporary use of cardiac imaging for COVID-19 patients: a three center experience defining a potential role for cardiac MRI

Panchal

Kyvernitakis

Mikolich

et al. 2021

Int J Cardiovasc Imaging

View full text Add to dashboard Cite

The pandemic of coronavirus disease 2019 (COVID-19) secondary to the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has bestowed an unprecedented challenge upon us, resulting in an international public health emergency. COVID-19 has already resulted in > 1,600,000 deaths worldwide and the fear of a global economic collapse. SARS-CoV-2 is notorious for causing acute respiratory distress syndrome, however emerging literature suggests various dreaded cardiac manifestations associated with high mortality. The mechanism of myocardial damage in COVID-19 is unclear but thought to be multifactorial and mainly driven by the host's immune response (cytokine storm), hypoxemia and direct myocardial injury by the virus. Cardiac manifestations from COVID-19 include but are not limited to, acute myocardial injury, cardiac arrhythmias, congestive heart failure and acute coronary syndrome. Cardiac imaging is paramount to appropriately diagnose and manage the cardiac manifestations of COVID-19. Herein, we present cardiac imaging findings of COVID-19 patients with biomarker and imaging confirmed myocarditis to provide insight regarding the variable manifestations of COVID-19 myocarditis via Cardiac MRI (CMR) coupled with CMR-edema education along with recommendations on how to incorporate advanced CMR into the clinicians' COVID-19 armamentarium.

show abstract

“…Образната диагностика на сърдечния мускул постепенно придоби ключова роля в неинвазивното откриване на миокардно възпаление, оценката на етиологията и проследяването на терапията [6]. Миокардитът обикновено се среща по-често при мъжете, отколкото при жените и честотата е най-висока при кърмачета, юноши и млади възрастни [7].…”

Section: въведениеunclassified

Миокардит След Имунизация С Първа Доза Информационна РНК Ваксина Срещу COVID-19

Стоименов¹,

Панчева²

2021

Редки болести и лекарства сираци

View full text Add to dashboard Cite

С оглед масовото приложение на иРНК ваксините в световен мащаб нарастват и случаите на пациенти, диагностицирани с миокардит. Поради изразената хетерогенност в клиничното протичане на това заболяване диагностицирането му лесно може да се пропусне. Мнозинството от регистрирани случаи са на млади мъже във възрастов диапазон между 15 и 29 години след завършен имунизационен цикъл. Представеният от нас клиничен случай е на 33-годишен мъж с анамнеза за прекаран перимиокардит преди 8 години и настъпили оплаквания след приложение на първа доза иРНК ваксина. Ранното диагностициране на миокардита дава възможност за навременно започване на кардиопротективна терапия, която да редуцира риска от развитие на внезапна сърдечна смърт, както и да подобри прогнозата при тези пациенти.

show abstract

Imaging of myocarditis and inflammatory cardiomyopathies

Cited by 24 publications

References 80 publications

COVID-19 and Myocarditis: What Do We Know So Far?

COVID-19 and Myocarditis: What Do We Know So Far?

Contemporary use of cardiac imaging for COVID-19 patients: a three center experience defining a potential role for cardiac MRI

Миокардит След Имунизация С Първа Доза Информационна РНК Ваксина Срещу COVID-19

Contact Info

Product

Resources

About